Black Rock Inc. Biofrontera Inc. Transaction History

Black Rock Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.4 - $0.65 $15,748 - $25,590	-39,370 Reduced 29.87%	92,420 $48,000
Q1 2023 May 12, 2023	BUY	$0.56 - $1.02 $6,613 - $12,046	11,810 Added 9.84%	131,790 $80,000
Q4 2022 Feb 13, 2023	BUY	$0.77 - $24.8 $1,071 - $34,521	1,392 Added 1.17%	119,980 $110,000
Q3 2022 Nov 14, 2022	BUY	$0.82 - $41.8 $6,418 - $327,168	7,827 Added 7.07%	118,588 $125,000
Q2 2022 Aug 12, 2022	BUY	$37.2 - $99.2 $381,523 - $1.02 Million	10,256 Added 10.2%	110,761 $206,000
Q1 2022 May 12, 2022	BUY	$45.0 - $138.4 $4.07 Million - $12.5 Million	90,394 Added 894.02%	100,505 $335,000
Q4 2021 Feb 10, 2022	BUY	$49.4 - $263.4 $499,483 - $2.66 Million	10,111 New	10,111 $76,000

Ticker BFRI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 23,551,000
Market Cap $30.1M
Description
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for phot...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.